chrX-120371125-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001142447.3(ATP1B4):āc.477C>Gā(p.Phe159Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,208,662 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.000011 ( 0 hom. 6 hem. )
Consequence
ATP1B4
NM_001142447.3 missense
NM_001142447.3 missense
Scores
2
2
13
Clinical Significance
Conservation
PhyloP100: 1.49
Genes affected
ATP1B4 (HGNC:808): (ATPase Na+/K+ transporting family member beta 4) This gene has been found in all vertebrate genomes sequenced to date. However, this gene has undergone a change in function in placental mammals compared to other species. Specifically, in fish, avian, and amphibian species, this gene encodes plasma membrane-bound beta-subunits of Na,K-ATPase. In placental mammals, the encoded protein interacts with the nuclear transcriptional coregulator SKIP and may be involved in the regulation of TGF-beta signaling. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.334248).
BS2
High Hemizygotes in GnomAdExome4 at 6 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATP1B4 | NM_001142447.3 | c.477C>G | p.Phe159Leu | missense_variant | 4/8 | ENST00000218008.8 | |
ATP1B4 | NM_012069.5 | c.465C>G | p.Phe155Leu | missense_variant | 4/8 | ||
ATP1B4 | XM_017029381.2 | c.477C>G | p.Phe159Leu | missense_variant | 4/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP1B4 | ENST00000218008.8 | c.477C>G | p.Phe159Leu | missense_variant | 4/8 | 1 | NM_001142447.3 | P1 | |
ATP1B4 | ENST00000361319.3 | c.465C>G | p.Phe155Leu | missense_variant | 4/8 | 1 | |||
ATP1B4 | ENST00000539306.5 | c.348C>G | p.Phe116Leu | missense_variant | 3/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 112009Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34171
GnomAD3 genomes
AF:
AC:
1
AN:
112009
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34171
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183402Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67846
GnomAD3 exomes
AF:
AC:
1
AN:
183402
Hom.:
AF XY:
AC XY:
1
AN XY:
67846
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000109 AC: 12AN: 1096653Hom.: 0 Cov.: 29 AF XY: 0.0000166 AC XY: 6AN XY: 362057
GnomAD4 exome
AF:
AC:
12
AN:
1096653
Hom.:
Cov.:
29
AF XY:
AC XY:
6
AN XY:
362057
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000893 AC: 1AN: 112009Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34171
GnomAD4 genome
AF:
AC:
1
AN:
112009
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34171
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.477C>G (p.F159L) alteration is located in exon 4 (coding exon 4) of the ATP1B4 gene. This alteration results from a C to G substitution at nucleotide position 477, causing the phenylalanine (F) at amino acid position 159 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;D;T
Polyphen
P;P;P
Vest4
MutPred
0.46
.;Gain of catalytic residue at M155 (P = 0.0469);.;
MVP
MPC
0.51
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at